Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® – May 2022 Page last updated: 26 August 2022 Public Summary Document (PSD) May 2022 PBAC Meeting - (PDF 962KB) Public Summary Document (PSD) May 2022 PBAC Meeting - (Word 366KB)